139 related articles for article (PubMed ID: 30507158)
1. Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx-1.
Lawrence N; Wu B; Ligutti J; Cheneval O; Agwa AJ; Benfield AH; Biswas K; Craik DJ; Miranda LP; Henriques ST; Schroeder CI
ACS Chem Biol; 2019 Jan; 14(1):118-130. PubMed ID: 30507158
[TBL] [Abstract][Full Text] [Related]
2. Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.
Agwa AJ; Peigneur S; Chow CY; Lawrence N; Craik DJ; Tytgat J; King GF; Henriques ST; Schroeder CI
J Biol Chem; 2018 Jun; 293(23):9041-9052. PubMed ID: 29703751
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.
Henriques ST; Deplazes E; Lawrence N; Cheneval O; Chaousis S; Inserra M; Thongyoo P; King GF; Mark AE; Vetter I; Craik DJ; Schroeder CI
J Biol Chem; 2016 Aug; 291(33):17049-65. PubMed ID: 27311819
[TBL] [Abstract][Full Text] [Related]
5. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
Murray JK; Ligutti J; Liu D; Zou A; Poppe L; Li H; Andrews KL; Moyer BD; McDonough SI; Favreau P; Stöcklin R; Miranda LP
J Med Chem; 2015 Mar; 58(5):2299-314. PubMed ID: 25658507
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
Moyer BD; Murray JK; Ligutti J; Andrews K; Favreau P; Jordan JB; Lee JH; Liu D; Long J; Sham K; Shi L; Stöcklin R; Wu B; Yin R; Yu V; Zou A; Biswas K; Miranda LP
PLoS One; 2018; 13(5):e0196791. PubMed ID: 29723257
[TBL] [Abstract][Full Text] [Related]
7. Molecular interactions of the gating modifier toxin ProTx-II with NaV 1.5: implied existence of a novel toxin binding site coupled to activation.
Smith JJ; Cummins TR; Alphy S; Blumenthal KM
J Biol Chem; 2007 Apr; 282(17):12687-97. PubMed ID: 17339321
[TBL] [Abstract][Full Text] [Related]
8. Changes in Potency and Subtype Selectivity of Bivalent Na
Tran P; Tran HNT; McMahon KL; Deuis JR; Ragnarsson L; Norman A; Sharpe SJ; Payne RJ; Vetter I; Schroeder CI
Bioconjug Chem; 2023 Jun; 34(6):1072-1083. PubMed ID: 37262436
[TBL] [Abstract][Full Text] [Related]
9. ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels.
Priest BT; Blumenthal KM; Smith JJ; Warren VA; Smith MM
Toxicon; 2007 Feb; 49(2):194-201. PubMed ID: 17087985
[TBL] [Abstract][Full Text] [Related]
10. Potency-Enhancing Mutations of Gating Modifier Toxins for the Voltage-Gated Sodium Channel Na
Katz D; Sindhikara D; DiMattia M; Leffler AE
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800031
[TBL] [Abstract][Full Text] [Related]
11. Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7.
Agwa AJ; Tran P; Mueller A; Tran HNT; Deuis JR; Israel MR; McMahon KL; Craik DJ; Vetter I; Schroeder CI
J Biol Chem; 2020 Apr; 295(15):5067-5080. PubMed ID: 32139508
[TBL] [Abstract][Full Text] [Related]
12. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
Murray JK; Long J; Zou A; Ligutti J; Andrews KL; Poppe L; Biswas K; Moyer BD; McDonough SI; Miranda LP
J Med Chem; 2016 Mar; 59(6):2704-17. PubMed ID: 26890998
[TBL] [Abstract][Full Text] [Related]
13. A complicated complex: Ion channels, voltage sensing, cell membranes and peptide inhibitors.
Zhang AH; Sharma G; Undheim EAB; Jia X; Mobli M
Neurosci Lett; 2018 Jul; 679():35-47. PubMed ID: 29684532
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent- and tagged-protoxin II peptides: potent markers of the Na
Montnach J; De Waard S; Nicolas S; Burel S; Osorio N; Zoukimian C; Mantegazza M; Boukaiba R; Béroud R; Partiseti M; Delmas P; Marionneau C; De Waard M
Br J Pharmacol; 2021 Jul; 178(13):2632-2650. PubMed ID: 33742442
[TBL] [Abstract][Full Text] [Related]
15. The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant.
Rahnama S; Deuis JR; Cardoso FC; Ramanujam V; Lewis RJ; Rash LD; King GF; Vetter I; Mobli M
PLoS One; 2017; 12(3):e0173551. PubMed ID: 28301520
[TBL] [Abstract][Full Text] [Related]
16. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
[TBL] [Abstract][Full Text] [Related]
17. Two tarantula peptides inhibit activation of multiple sodium channels.
Middleton RE; Warren VA; Kraus RL; Hwang JC; Liu CJ; Dai G; Brochu RM; Kohler MG; Gao YD; Garsky VM; Bogusky MJ; Mehl JT; Cohen CJ; Smith MM
Biochemistry; 2002 Dec; 41(50):14734-47. PubMed ID: 12475222
[TBL] [Abstract][Full Text] [Related]
18. Expression, Purification and Refolding of a Human Na
Schroder RV; Cohen LS; Wang P; Arizala JD; Poget SF
Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679015
[TBL] [Abstract][Full Text] [Related]
19. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.
Murray JK; Biswas K; Holder JR; Zou A; Ligutti J; Liu D; Poppe L; Andrews KL; Lin FF; Meng SY; Moyer BD; McDonough SI; Miranda LP
Bioorg Med Chem Lett; 2015 Nov; 25(21):4866-4871. PubMed ID: 26112439
[TBL] [Abstract][Full Text] [Related]
20. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
